Skip to Content
4

SEC Filing Details

Document Details

Form
Filing Date
Apr 17, 2019
Document Date
Apr 15, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Merrimack Pharmaceuticals
Issuer
MERRIMACK PHARMACEUTICALS INC
Filer
22NW Fund, LP